Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 million lives each year.

Clearmind Medicine : Condensed Interim Consolidated Financial Statements – Form 6-K | Psychedelic Invest

For The Three and Nine Months Ended July 31, 2023 (Expressed in United States Dollars) (Unaudited) Condensed Interim Consolidated Statements of Financial Position (Expressed in

September 13, 2023

Cytisinicline Shows Efficacy for Smoking Cessation

Cytisinicline safely and effectively helped people quit smoking when used at a higher concentration than is traditional in Europe, the placebo-controlled ORCA-2 trial found. Administered

July 12, 2023

Machine learning model predicts CDK4/6 inhibitor effectiveness in metastatic breast cancer

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients

December 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.